BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34108971)

  • 1. CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1.
    Zeisbrich M; Chevalier N; Sehnert B; Rizzi M; Venhoff N; Thiel J; Voll RE
    Front Immunol; 2021; 12():673912. PubMed ID: 34108971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMTM6, a potential immunotherapy target.
    Liang J; Li S; Li W; Rao W; Xu S; Meng H; Zhu F; Zhai D; Cui M; Xu D; Cai J; Zhang B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):47-56. PubMed ID: 34783871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished PD-L1 regulation along with dysregulated T lymphocyte subsets and chemokine in ANCA-associated vasculitis.
    Singh J; Minz RW; Saikia B; Nada R; Sharma A; Jha S; Anand S; Rathi M; D'Cruz S
    Clin Exp Med; 2023 Sep; 23(5):1801-1813. PubMed ID: 36219364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression.
    Wang H; Gao J; Zhang R; Li M; Peng Z; Wang H
    Int Immunopharmacol; 2020 Jun; 83():106478. PubMed ID: 32278132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer.
    Wu X; Lan X; Hu W; Zhang W; Lai X; Xu S; Li J; Qiu W; Wang W; Xiao J; Wang F; Ding Y; Liang L
    Cancer Immunol Immunother; 2021 Nov; 70(11):3235-3248. PubMed ID: 33818637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Loss of Immune Checkpoint Programmed Cell Death Protein 1 and Active ANCA-Associated Renal Vasculitis.
    Hakroush S; Tampe B
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1.
    Miao B; Hu Z; Mezzadra R; Hoeijmakers L; Fauster A; Du S; Yang Z; Sator-Schmitt M; Engel H; Li X; Broderick C; Jin G; Gomez-Eerland R; Rozeman L; Lei X; Matsuo H; Yang C; Hofland I; Peters D; Broeks A; Laport E; Fitz A; Zhao X; Mahmoud MAA; Ma X; Sander S; Liu HK; Cui G; Gan Y; Wu W; Xiao Y; Heck AJR; Guan W; Lowe SW; Horlings HM; Wang C; Brummelkamp TR; Blank CU; Schumacher TNM; Sun C
    Cancer Cell; 2023 Oct; 41(10):1817-1828.e9. PubMed ID: 37683639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.
    Hid Cadena R; Reitsema RD; Huitema MG; van Sleen Y; van der Geest KSM; Heeringa P; Boots AMH; Abdulahad WH; Brouwer E
    Front Immunol; 2019; 10():1638. PubMed ID: 31379838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis.
    Miyabe C; Dong Y; Ikeda T; Takahashi K; Miyabe Y; Kawakami T
    Sci Rep; 2021 Oct; 11(1):20019. PubMed ID: 34625602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma.
    Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Morinaga A; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
    Hepatol Commun; 2021 Feb; 5(2):334-348. PubMed ID: 33553979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
    Shang X; Li J; Wang H; Li Z; Lin J; Chen D; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106864. PubMed ID: 32866782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMTM6 as a master regulator of PD-L1.
    Yaseen MM; Abuharfeil NM; Darmani H
    Cancer Immunol Immunother; 2022 Oct; 71(10):2325-2340. PubMed ID: 35294592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma.
    Liu LL; Zhang SW; Chao X; Wang CH; Yang X; Zhang XK; Wen YL; Yun JP; Luo RZ
    Cancer Immunol Immunother; 2021 Feb; 70(2):417-429. PubMed ID: 32770259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT.
    Xiao M; Duhem C; Chammout A; Berchem G; Janji B
    J Cell Biochem; 2022 Jun; 123(6):1025-1031. PubMed ID: 35575054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
    de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
    Front Immunol; 2020; 11():574491. PubMed ID: 33193363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of monocytes in ANCA-associated vasculitides.
    Brunini F; Page TH; Gallieni M; Pusey CD
    Autoimmun Rev; 2016 Nov; 15(11):1046-1053. PubMed ID: 27491570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.